Category: compounded
-
US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters
•
(Reuters) – The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors linked to combination versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalization, that may have been linked to overdoses caused…